These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [FIP1L1-PDGFRalpha-positive myeloproliferative disease with hypereosinophilia: clinical characteristics and pathogenetic therapy]. Nemchenko IS; Khoroshko ND; Turkina AG; Sokolova MA; Kokhno AV; Semenova EA; Zakharova AV Ter Arkh; 2005; 77(7):90-2. PubMed ID: 16116920 [No Abstract] [Full Text] [Related]
24. Acute myeloid leukaemia with associated eosinophilia: justification for FIP1L1-PDGFRA screening in cases lacking the CBFB-MYH11 fusion gene. Sorour Y; Dalley CD; Snowden JA; Cross NC; Reilly JT Br J Haematol; 2009 Jul; 146(2):225-7. PubMed ID: 19466970 [No Abstract] [Full Text] [Related]
25. Osteolytic lesion as initial presentation in FIP1L1-PDGFRA-rearranged myeloid/lymphoid neoplasm with eosinophilia: a case report. Lv Y; Yao X; Ling Q; Suo S; Wang J; Zhao S; Gao X; Tong H; Jin J; Zhang X; Yu W Ann Hematol; 2024 Jan; 103(1):357-360. PubMed ID: 37777636 [No Abstract] [Full Text] [Related]
26. PDGFRᵝ-Rearranged Myeloid Neoplasm with Marked Eosinophilia in a 37-Year-Old Man; And a Literature Review. Andrei M; Bandarchuk A; Abdelmalek C; Kundra A; Gotlieb V; Wang JC Am J Case Rep; 2017 Feb; 18():173-180. PubMed ID: 28209946 [TBL] [Abstract][Full Text] [Related]
27. Unique association of myeloid neoplasm with eosinophilia and abnormalities of PDGFRA with TTP. Chaudhary LN; Bailey NG; Vos JA; Stotler CJ W V Med J; 2013; 109(2):6-9. PubMed ID: 23600098 [TBL] [Abstract][Full Text] [Related]
28. FIP1L1-PDGFRA in eosinophilic disorders: prevalence in routine clinical practice, long-term experience with imatinib therapy, and a critical review of the literature. Pardanani A; Ketterling RP; Li CY; Patnaik MM; Wolanskyj AP; Elliott MA; Camoriano JK; Butterfield JH; Dewald GW; Tefferi A Leuk Res; 2006 Aug; 30(8):965-70. PubMed ID: 16406016 [TBL] [Abstract][Full Text] [Related]
29. Eosinophilia with FIP1L1-PDGFRA fusion in a patient with chronic myelomonocytic leukemia. Zota V; Miron PM; Woda BA; Raza A; Wang SA J Clin Oncol; 2008 Apr; 26(12):2040-1. PubMed ID: 18421057 [No Abstract] [Full Text] [Related]
30. Imatinib therapy for hypereosinophilic syndrome and eosinophilia-associated myeloproliferative disorders. Pardanani A; Tefferi A Leuk Res; 2004 May; 28 Suppl 1():S47-52. PubMed ID: 15036941 [TBL] [Abstract][Full Text] [Related]
33. FIP1L1-PDGFRalpha alone or with other genetic abnormalities reveals disease progression in chronic eosinophilic leukemia but good response to imatinib. Wang LN; Pan Q; Fu JF; Shi JY; Jin J; Li JM; Hu J; Zhao WL; Chen Z; Chen SJ Chin Med J (Engl); 2008 May; 121(10):867-73. PubMed ID: 18706197 [TBL] [Abstract][Full Text] [Related]
34. Detection of FIP1L1-PDGFRA fusion by FISH. Ma ES; Wong KF; Wong CL; Siu LL Br J Haematol; 2007 Aug; 138(3):279. PubMed ID: 17542982 [No Abstract] [Full Text] [Related]
35. Imatinib mesylate can induce complete molecular remission in FIP1L1-PDGFR-a positive idiopathic hypereosinophilic syndrome. Martinelli G; Malagola M; Ottaviani E; Rosti G; Trabacchi E; Baccarani M Haematologica; 2004 Feb; 89(2):236-7. PubMed ID: 15003901 [No Abstract] [Full Text] [Related]
36. Myeloid neoplasm with eosinophilia associated with isolated extramedullary FIP1L1/PDGFRA rearrangement. Hilal T; Fauble V; Ketterling RP; Kelemen K Cancer Genet; 2018 Jan; 220():13-18. PubMed ID: 29310833 [TBL] [Abstract][Full Text] [Related]
37. Marked eosinophilic atypia in a patient with asthma and myeloid/lymphoid neoplasm with FIP1L1::PDGFRA fusion. Deb PQ; Li L Br J Haematol; 2024 Jul; 205(1):14. PubMed ID: 38685615 [No Abstract] [Full Text] [Related]
38. A neoplasm with FIP1L1-PDGFRA fusion presenting as pediatric T-cell lymphoblastic leukemia/lymphoma without eosinophilia. Oberley MJ; Denton C; Ji J; Hiemenz M; Bhojwani D; Ostrow D; Wu S; Gaynon P; Raca G Cancer Genet; 2017 Oct; 216-217():91-99. PubMed ID: 29025601 [TBL] [Abstract][Full Text] [Related]
39. Myeloid neoplasms associated with eosinophilia and rearrangement of PDGFRA, PDGFRB, and FGFR1: a review. Savage N; George TI; Gotlib J Int J Lab Hematol; 2013 Oct; 35(5):491-500. PubMed ID: 23489324 [TBL] [Abstract][Full Text] [Related]